Cellular Dynamics International, Madison, has created a company, Opsis Therapeutics, to develop treatments that could restore vision to patients with diseases of the retina....
Amgen, one of the world's leading biotechnology companies, is teaming with Arrowhead Pharmaceuticals to bring two drugs to market to treat cardiovascular disease in a deal worth more than $50 million to start with the potential for another $600 million or more in the future....
With spin-off investments Grail and Helix, and a new software-savvy CEO, Illumina is poised to make DNA an even bigger part of your life....
Governor Scott Walker joined Bunker Labs Wisconsin, Inc. to announce the launch of The Muster-Madison, a daylong event at the Wisconsin State Capitol that highlights interaction that will inspire, educate, and connect military veteran entrepreneurs to the startup community, business leaders, and each other....
The Madworks Seed Accelerator is now seeking startups to participate in its Fall 2016 program. Participants receive $5,000 for completing the 10-week session....
The University of Wisconsin-Madison ranked 14th among all universities in the world in a count of how many venture capital-backed entrepreneurs it has spawned, according to a report by Pitchbook Data....
Arrowhead Pharmaceuticals has initiated a Phase 2 clinical trial for its drug candidate aimed at treating rare liver diseases associated with alpha-1 antitrypsin (AAT) deficiency....
Cellular Dynamics International (CDI) has changed its structure, dividing into two separate business units: Therapeutics, to develop stem cell-based drugs, and Life Science, focusing on research products....
The Master of Science in Biotechnology program welcomed its 15th cohort of working professionals during its annual new student orientation this August....
Stratatech Corp., whose human skin tissue products are used to heal severe burns, is now part of the UK's Mallinckrodt Pharmaceuticals but will stay in Madison and keep all of its 55 jobs....